Geographic and area-level socioeconomic variation in cardiometabolic risk factor distribution: a systematic review of the literature by Melkias Baby Selvi Toms, Renin et al.
University of Wollongong
Research Online
Illawarra Health and Medical Research Institute Faculty of Science, Medicine and Health
2019
Geographic and area-level socioeconomic variation
in cardiometabolic risk factor distribution: a
systematic review of the literature
Renin Melkias Baby Selvi Toms
University of Wollongong, rmbst288@uowmail.edu.au
Andrew D. Bonney
University of Wollongong, abonney@uow.edu.au
Darren J. Mayne
University of Wollongong, Illawarra Shoalhaven Local Health District, dmayne@uow.edu.au
Xiaoqi Feng
University of Wollongong, xfeng@uow.edu.au
Ramya Walsan
University of Wollongong, rw931@uowmail.edu.au
Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library:
research-pubs@uow.edu.au
Publication Details
Toms, R., Bonney, A., Mayne, D. J., Feng, X. & Walsan, R. (2019). Geographic and area-level socioeconomic variation in
cardiometabolic risk factor distribution: a systematic review of the literature. International Journal of Health Geographics, 18 1-1-1-12.
Geographic and area-level socioeconomic variation in cardiometabolic
risk factor distribution: a systematic review of the literature
Abstract
Introduction: A growing number of publications report variation in the distribution of cardiometabolic risk
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service organisation.
Aim: To review studies reporting variation in the geographic distribution of CMRFs and its association with
various proxy measures of area-level socioeconomic disadvantage (ASED) among the adult ( ≥ 18 years)
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Result: A total of 265 studies were retrieved and screened, resulting in 24 eligible studies. The review revealed
reports of variation in the distribution of CMRFs, at varying geographic scales, in multiple countries. In
addition, consistent associations between ASED and higher prevalence of CMRFs were demonstrated. The
reports were mainly from industrialised nations and small area geographic units were frequently used.
Conclusion: Geographic variation in cardiometabolic risk exists across multiple spatial scales and is positively
associated with ASED. This association is independent of individual-level factors and provides an imperative
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Geographic and area-level socioeconomic 
variation in cardiometabolic risk factor 
distribution: a systematic review of the literature
Renin Toms1* , Andrew Bonney1,2, Darren J. Mayne1,2,3, Xiaoqi Feng2,4 and Ramya Walsan1
Abstract 
Introduction: A growing number of publications report variation in the distribution of cardiometabolic risk fac-
tors (CMRFs) at different geographic scales. A review of these variations may help inform policy and health service 
organisation.
Aim: To review studies reporting variation in the geographic distribution of CMRFs and its association with various 
proxy measures of area-level socioeconomic disadvantage (ASED) among the adult ( ≥ 18 years) population across 
the world.
Methods: A systematic search for published articles was conducted in four databases (MEDLINE (Ovid), PubMed, 
Scopus and Web of Science) considering the interdisciplinary nature of the review question. Population-based cross-
sectional and cohort studies on geographic variations of one or more biological proxies of CMRFs with/without an 
analysed contextual association with ASED were included. Two independent reviewers screened the studies and 
PRISMA guidelines were followed in the study selection and reporting.
Result: A total of 265 studies were retrieved and screened, resulting in 24 eligible studies. The review revealed reports 
of variation in the distribution of CMRFs, at varying geographic scales, in multiple countries. In addition, consistent 
associations between ASED and higher prevalence of CMRFs were demonstrated. The reports were mainly from 
industrialised nations and small area geographic units were frequently used.
Conclusion: Geographic variation in cardiometabolic risk exists across multiple spatial scales and is positively associ-
ated with ASED. This association is independent of individual-level factors and provides an imperative for area-based 
approaches to informing policy and health service organisation. The study protocol is registered in International 
prospective register of systematic reviews (Register No: CRD42018115294) PROSPERO 2018.
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Introduction
Cardiovascular disease (CVD) associated metabolic risk 
factors represent major global public health concerns. 
CVD is the leading cause of human death, accounting 
for 17.7 million (31%) of the 56.4 million total deaths 
reported worldwide in 2015 [1]. Coronary heart disease 
(7.4 million) and stroke (6.7 million) were responsible for 
the greatest mortality within CVD and have remained the 
leading cause for mortality for the last 15 years [2]. CVD 
and its associated metabolic risk factors are listed in the 
top 15 causes of disability adjusted life years (DALY) 
globally [3]. In keeping with historical trends, deaths due 
to CVD are projected to increase steeply and reach more 
than 23.6 million annually by 2030 [4].
An important way to control CVD is by focussing 
on reducing associated metabolic risk factors. In low 
resource settings, vulnerable and disadvantaged groups 
are more likely to be exposed to unhealthy products 
and practices and develop metabolic risk factors for the 
development of CVD [5]. Cardiometabolic risk factors 
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(CMRFs) such as diabetes mellitus (DM), hyperlipidae-
mia, high body mass index (BMI), and chronic kidney 
disease (CKD) can predispose and worsen CVD. Indi-
vidual level approaches to prevent and control these risk 
factors have demonstrated limited success as evidenced 
by its increasing rates [6–8]. Thus it is important, in 
addition, to discern the contextual associations of devel-
opment of these risk factors to assist in mitigating this 
global epidemic.
Geographic inequalities in the distribution of CMRFs 
at varying scales are reported in multiple studies from 
different countries in association with area-level socio-
economic disadvantage (ASED). Reviewing the area level 
distribution patterns and associated area level disadvan-
tages reported in these studies may deepen our under-
standing of the higher prevalence of CMRFs in some 
geographic areas. Most recent relevant reviews in this 
area have broadly covered the influence of physical, social 
and service environment characteristics on CVD risk 
[9–12]. However, the potentially important influence of 
ASED is critically under-examined. Systematic synthesis 
of evidence regarding this globally reported variation and 
association can inform policy development and health-
care service planning to detail area level approaches, in 
addition to individual level measures, to prevent and con-
trol CMRFs effectively.
Therefore, the questions attempted to answer in this 
review are: Is there any geographic variation in the dis-
tribution of CMRFs among the  adult population (aged 
18 years and above) across the world, and is this variation 
associated with ASED? The studies expected to include 
were epidemiological or population based cross sectional 
and/or cohort studies.
Methods
A review protocol was developed and registered in 
International prospective register of systematic reviews, 
PROSPERO 2018 (Register No: CRD42018115294) Avail-
able from: http://www.crd.york.ac.uk/PROSP ERO/displ 
ay_recor d.php?ID=CRD42 01811 5294.
Four databases; MEDLINE (Ovid), PubMed, Scopus 
and Web of science databases were chosen for the search, 
considering the breadth of fields they cover and the inter-
disciplinary nature of the review question. Also, hand-
searches of related articles served as ‘other sources’ of 
studies. The database search strategy commenced with 
two general search domains [1]: studies on CMRFs in sin-
gular and composite forms; and [2] geographic and spa-
tial health studies. An intersectional retrieval of studies 
from both these domains yielded a narrower list of stud-
ies on geographic variation in CMRFs. A third domain [3] 
studies addressing area-level measures of socioeconomic 
disadvantages were further intersected with the retrieved 
studies to create a focal list of studies addressing geo-
graphic association of CMRFs with ASED. This approach 
maximised the number of potentially eligible studies 
identified compared to using single domain searches. Fig-
ure 1 conceptualizes the major search domains and their 
intersections used in the review.
The review included epidemiological or population-
based cross-sectional and cohort studies on: geographic 
variation of one or more biological proxies of CMRFs, 
with/without an analysed contextual association with 
ASED. Obesity, diabetes mellitus (DM), hyperlipidaemia, 
and indices of low kidney function were the included bio-
logical proxies of CMRFs. Hypertension is included only 
when reported with other biological proxies of CMRFs, 
but not independently considering its limited summa-
tion into an overall cardiometabolic risk in an individual. 
Studies involving type 1 DM and gestational DM were 
excluded as they were out of scope for the current review 
pertaining to  the geographic or area based contexts of 
the CMRFs. Studies measuring area-level characteristics 
other than ASED were also excluded.
All search outcomes were limited to: human studies; 
adult population (≥ 18  years); and availability in Eng-
lish language. The initial search included studies from 
year 1995; and latter it was modified to 01/01/2001 due 
to minimal publications on the review topic between 
the years 1995–2000. The search was last updated on 
30/11/2018. Adopted search strategy in Ovid MEDLINE, 
and search result URLs of remaining databases are avail-
able in Additional file 1.
All retrieved studies were screened by two independ-
ent reviewers (RT and RW) in three stages to reduce the 
risk of bias. In stage 1, articles from all databases were 
combined and screened to remove duplicates. Titles and 
abstracts of remaining articles were screened for eligibil-
ity in stage 2. The final stage of study selection was done 
after full text reading of the remaining studies. Qualities 
of the individual studies were assessed using the STROBE 
checklist for cohort, case–control and cross-sectional 
studies (www.strob e-state ment.org). The second coder 
repeated all three stages in parallel, and selected studies 
were matched at the conclusion of each stage and any 
differences were resolved by consensus and arbitration. 
Other review team members (AD, DJM and XF) served 
as additional reviewers when required.
Data extraction and coding of the chosen studies were 
carried out using two pilot-tested templates for consist-
ency. Template 1 focused on the geographic variation in 
CMRFs and was used to extract information on author, 
year, nation, study design, sample size and characteris-
tics, geographic unit of reporting, studied CMRFs, and 
the study outcome. Data on behavioural risk factors were 
not extracted as these were not included in the current 
Page 3 of 12Toms et al. Int J Health Geogr            (2019) 18:1 
review. Template 2 addressed the association of ASED 
and cardiometabolic risk prevalence, and extracted 
additional data on the reported proxies of ASED and 
its association status. An additional template was used 
for thematic mapping of the data in included studies for 
further qualitative syntheses. Study origin, representa-
tion, nature of problem, ecological context, and evidence 
strength were the mapped themes.
The two independent review authors extracted and 
coded the data, and any discrepancies were resolved 
through discussions between the authors. Summary 
measures used in this review are descriptive and based 
on the frequency of relevant studies to its denomina-
tor. Endnote software was used to keep track of the bib-
liographic details of the studies throughout the selection 
and data extraction process.
Results
A total of 265 individual studies were retrieved from four 
electronic databases (n = 251) and hand searches of ref-
erence lists (n = 14). Studies from electronic data bases 
included 91 Ovid Medline, 80 PubMed, 58 Scopus, and 
22 Web of science publications.
Figure  2 shows the screening process as per the Pre-
ferred Reporting Items for Systematic Reviews and 
Meta-Analyses PRISMA guidelines (www.prism a-state 
ment.org) [13]. Stage 1 screening combined studies from 
all sources and removed the duplicates (n = 99). Dupli-
cates in removed order: Ovid Medline (n = 0); PubMed 
(n = 80); Scopus (n = 10); Web of science (n = 3); and 
hand-searches (n = 6). After removing duplicates, 166 
studies were forwarded for stage 2 screening. Stage 2 
screening excluded 130 studies based on title and abstract 
screens, forwarding 36 studies for the full text screen. 
Studies excluded in stage 2 mainly addressed genetic, cel-
lular, instrumental or pharmacological research regard-
ing CMRFs. Studies on type 1 DM, paediatric or juvenile 
DM and gestational DM were also excluded at this stage 
as per the exclusions stated. Stage 3 screening carefully 
considered the whole full text of articles and 12 records 
were excluded with reason (list available in Additional 
file  2) leaving 24 studies for the systematic synthe-
sis.  PRISMA 2009   guidelines are  followed in reporting 
the review and the checklist available in Additional file 3.
The review is structured into three sections. Screened 
research articles retrieved through ‘AND’ intersec-
tions of search domain 1 and 2 (n = 8) are reviewed in 
Fig. 1 Conceptual representation of the literature search strategy
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“Introduction” section: Geographic variation in the prev-
alence of cardiometabolic risk factors. Screened articles 
retrieved by intersecting domains 1 and 3 (n = 16) are 
reviewed in “Methods” section: Area level deprivation 
and cardiometabolic risk prevalence. Overall synthesis 
based on the total reviewed studies (n = 24) is presented 
in “Results” section: Overall synthesis of the studies.
Geographic variation in the prevalence of cardiometabolic 
risk factors
Table  1 summarizes the eight studies reviewed under 
this section [13–20]. Geographic variation in the 
prevalence of one or more CMRFs is reported in each 
of these studies. Most of the studies (7/8) reported 
hyperglycaemia as an important biomarker displaying 
geographic variation in cardiometabolic risk [13–18, 
20,] followed by dyslipidaemia (4/8), body mass index 
(4/8), blood pressure (BP) (3/8) and reduced glomeru-
lar filtration rate (GFR) (1/8).
All studies reported geographic variation in the prev-
alence of CMRFs, regardless of the geographic unit of 
analysis used [13–20]. Most of these studies were from 
Europe (4/8), predominantly from Western Europe 
(3/8) [15, 16, 18, 19]. These reports were from UK, [19] 
Spain, [18] France, [16] and Luxembourg [15]. In the 
UK, geographic variation in the prevalence of risk fac-
tors such as obesity, smoking, diabetes, hypertension 
and high cholesterol were reported across four main 
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Fig. 2 Combined PRISMA flow chart of the study selection
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regions: South England: Midlands: and Wales: Scotland: 
and North England [19]. A higher prevalence of CMRFs 
was reported in southern Spain (Andalusia), which was 
found in close association with sedentary lifestyle and 
markers of socioeconomic disadvantage [18]. Variation 
in the distribution of diabetes, high BMI (≥ 25 kg/m2), 
abdominal obesity, hypertension, high cholesterol and 
low glomerular filtration rate were reported at both 
canton and municipality levels in Luxemburg, Western 
Europe [15].
BMI and resting heart rate were reported to have 
greater geographic variation among matched cohorts in 
France and Australia [16].
Other reports in this section were from Oceania (2/8), 
East Asia (2/8) and North America 1/8)—sourced from 
Australia, China, South Korea and US [13, 14, 16, 17, 20]. 
A geographic variation of 42% was reported in the odds 
of being diagnosed with DM among adults in Sydney, 
Australia [14]. In another Australian metropolitan based 
cohort, glycated haemoglobin (HbA1c) was reported to 
have geographic variation among matched cohorts in 
Australia and France [16]. In China, significant varia-
tion in the regional prevalence of diabetes was reported 
after adjusting for age, sex and urban/rural socioeco-
nomic circumstances [17]. Geographic clustering of car-
diometabolic risk factors were reported at administrative 
district level in South Korea [13]. The presence of a ‘dia-
betic belt’ with higher prevalence of diagnosed diabetes 
(> 11.0%) was reported in the United States, consisting of 
644 counties in its 15 mostly southern states [20]. Though 
the risk profiles and parameters varied, all these studies 
consistently reported geographic variation in its CMRFs.
The geographic scales of area-based units reported in 
all these studies ranged from large regions [17–19] within 
countries to smaller jurisdictional administration units 
[13–16, 20] and trended towards smaller geographic 
areas over time. Easily accessible pre-existing geographic 
units and boundaries were used in these studies but most 
weren’t explicit on the spatial extention and average pop-
ulation within their geographic units. Three studies had 
relied only on self-reports on anthropometric, behav-
ioural, biochemical, physiological and diagnostic catego-
ries of data, risking for recall bias and misclassifications 
[13, 14, 20].
Area level deprivation and cardiometabolic risk prevalence
Table  2 summarises the 16 studies reviewed under this 
section [21–36]. Reported studies were mainly from 
Europe (7/16) and North America (7/16), followed by 
Oceania (1/16) and South America (1/16). Studies from 
Europe were predominantly reported from the western 
Table 1 List of studies reviewed on geographic variation in CMRFs
AU Australia, CD census collection district, POA postal area, SLA statistical local area, LGA local government area, IRIS Ilôts regroupés pour l’information statistique, 
TRIRIS groups of around three IRIS areas, BP blood pressure, BMI body mass index, DM diabetes mellitus, FBG fasting plasma glucose, FPG fasting glucose, HbA1c 
glycated haemoglobin, HR heart rate, HT hypertension, TC total cholesterol; TG triglycerides, LDL low density lipoprotein, GFR glomerular filtration rate, WC waist 
circumference
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4 regions within country
HT, BMI, LDL, TC (data collected) Geographic variation





644 counties in proximity
DM prevalence ≥ 11.0%, (behavioral risk 
factor surveillance)
Geographic diabetic belt





2 region within country
BP, BMI, FPG,TC, WC (Di@bet.es study) Geographic coherence





~ 40 local government 
areas (2011 significant urban 
boundary)
DM (the 45 and up study) Geographic variation





31 provinces in country
DM (National Health Survey) Geographic variation
6 Paquet et al.
AU-France [16]
Au: 3893 (≥ 18 years)
Fr: 6430 (30–79 years)
Cross-sectional multilevel
Au: 767 CDs (SS, POA, SLA LGA). 
Fr: 1866 IRIS (TRIRIS, Municipali-
ties)
BP,BMI,WC,FG,HbA1c,HR, TC,HDL, TG, 
(Au: NWAHS study, Fr: RECORD cohort 
study)
Geographic clustering





106 municipalities (12 cantons)
BMI, FPG,TC, GFR (ORISCAV-LUX national 
survey)
Geographic variation






HT, DM (Korean Community Health 
Surveys)
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region and sourced from UK, Germany, Czech Republic 
and France. Reports from North America were mainly 
from USA (6/7) and Canada (1/7). There was only one 
study from Oceania, sourced from Australia [26]. Most 
of these studies were sourced from industrialised nations, 
except one study from Brazil, [21] a developing nation in 
South America.
All studies reported associations of higher prevalence 
of CMRFs with greater ASED [21–36]. Various meas-
ures of the biological proxies of CMRFs reported includ 
biochemical, anthropometric, physiologic, behavioural 
and diagnostic categories of data. Census sourced data 
on ASED were used in most of these studies (12/16), 
whereas other survey sourced data were used in the 
remaining studies (4/16) to construct summary scores 
or indices on ASED. The categories of measures used to 
calculate ASED in these studies were area-level propor-
tions of: median income; education; occupation; housing; 
transport; dependent population; social class; social capi-
tal; environment; security; family structure; disability; 
internet access; and insurance coverage. A minimum of 
one category of these measures were used in all the stud-
ies [21–36].
The samples characteristics and variables considered 
were notably heterogeneous across studies. The sam-
pling frame of most (7/16) of these studies were popu-
lation based lists, however service provider (4/16) and 
employee (3/16) lists were also used. Two studies had 
used a combination of both population lists and ser-
vice provider given lists [27, 30]. Though subjects in all 
studies used adult age limits (≥ 18  years), divergent age 
groups were sampled across all of the studies. Also gen-
der [34, 35] and race [22, 23] specific sampling were used 
in two studies each. Heterogeneity of these sample char-
acteristics makes a comparison and further quantitative 
synthesis difficult.
The samples were mostly accessed from existing study 
cohorts, laboratory databases, national surveys and audit 
lists. The sample size of studies ranged from 342 adults 
to a maximum of 91,776 adults, mostly larger in size. 
Census administration units were the most commonly 
used neighbourhood proxy, followed by other adminis-
trative units and electoral wards. Pre-existing geographic 
boundaries were mostly adopted to define the spatial 
unit, but their spatial extents of the unit of analyses were 
not stated in most of the studies.
Overall synthesis of the studies
Significant features of the included studies were identi-
fied to aid synthesis of the findings. These features were 
the origin of the study, its representativeness, nature 
of the CMRFs studied, the ecological context and the 
strength of evidence presented. These features were then 
formulated into five themes, mapping the related data for 
further analyses (Table 3).
We had plotted all the  included studies to identify 
their global region of origin and the economic nature 
of the source country. Most of the studies published 
were from Europe (11/24), closely followed by America 
(9/12), (two studies were cross national, hence counted 
under both the nations and corresponding regions). 
Fewer publications were found from Oceania (3/24), 
and Asia (2/24).  However no identified studies were 
from Africa. Studies from developing nations were 
fewer (3/24) compared with studies from industrialised 
nations (21/24). This emphasises a gap in related pub-
lications from Asia–pacific and African regions, espe-
cially from nations of developing and underdeveloped 
economies. The global representativeness of this review 
is hence limited, and the review findings may be more 
generalizable to industrialised nations.
The target populations for included studies are shown 
in Table  3. The sample frame of most of the studies 
were population based lists (13/24 studies), however 
service providers’ lists (5/24) and employees lists (3/24) 
were also used. Both population and service providers’ 
lists were used in three studies (3/24). All the popula-
tion based studies used a random sampling technique 
to ensure the population representativeness. However, 
the response rates varied (15–90.5%) in these stud-
ies. Two studies had a response rate < 50%, suggesting 
a risk of responder bias despite a probability sampling 
method being employed [29, 36].
Ecological contexts of the included studies were ana-
lysed by extracting area level characteristics (Table  3). 
Area level units used in these studies extended from 
small areas (10/24), to medium areas (9/24) and large 
areas (5/24). Small area units were mostly based on 
census, administrative or zip code area with an aver-
age ~ 1000 residing population. Medium area units had 
an average ~ 5000 population and the large area units 
were mostly regions, provinces and districts. ASED 
gradients were based on area level measures of ranged 
from 1 to 7 measures, however single measures of 
income or overcrowding as an indirect proxy of ASED 
raised concerns regarding their comprehensiveness in 
comparison to aggregate measures of ASED.
The nature of CMRFs and the strength of evidence in 
relation to associations with outcomes were mapped by 
extracting data on the categories of CMRFs measured, 
the source of data and the mode of analyses (Table 3). 
Biological proxy categories of CMRFs were mostly bio-
chemical (18/24), followed by anthropometric (18/24), 
physiologic (15/24), and diagnostic (4/24) in nature. 
Self-reported data on these categories of CMRFs had 
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Table 3 Thematic mapping of data categories from all included studies
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the highest risk for misclassification due to reporting 
bias or errors. Studies which adopted a combined mode 
of both statistical and spatial analyses provided a better 
ecological context of CMRFs than with statistical analy-
ses alone.
Discussion
ASED was repeatedly demonstrated to be associated with 
higher cardiometabolic risk. Higher ASED was consist-
ently reported to have an association with cardiovascular 
risk; whereas lower ASED was associated with reduced 
cardiovascular risk. Such associations were often demon-
strated independently of individual level characteristics 
such as socioeconomic status, education and duration 
of exposure to area. Type 2 diabetes and high body mass 
index (BMI) were reported to be more prevalent in dis-
advantaged areas. Related studies report that the type of 
neighbourhood food outlets [37–39], poor physical activ-
ity resources [39], individual perception of area level fea-
tures [40] residential density and service availability [41] 
were all explanatory variables associated with cardiomet-
abolic risk prevalence among people living in disadvan-
taged neighbourhoods.
Related systematic reviews published in this area 
of research investigate associations for different geo-
graphically distributed factors with CVD. Chaix (2009) 
reviewed the associations between neighbourhood 
social environments and CHD, and proposed a theoreti-
cal model of a mediating mechanism focussing on the 
social interactional environment [10]. Consistent associa-
tions of obesity or hypertension with lower levels of area 
socioeconomic status, urbanization, street intersection, 
accessibility to supermarkets, social cohesion, service 
availability and residential density; and higher levels of 
Table 3 (continued)
















17. Maier et al. [29]
Germany(Industrialised)






























ASED: income, education, 
employment, family 
structure, disability, 














21. Paquet et al. [16]
AU-France
(Industrialised)
Oceania - West Europe
Australia: Population list
(Random 13/49.4% 












































Page 10 of 12Toms et al. Int J Health Geogr            (2019) 18:1 
noise pollution and density of convenience stores, were 
reviewed and reported by Leal [11]. Frequent inverse 
associations of the common indices of ASED with child-
hood obesity were reported in the UK [9]. Consistent 
associations between socio economic disadvantage and 
central adiposity was reported by Slopen [12]. All these 
reviews report important methodological inadequacies 
and the need for further research in this area, which sup-
port the findings of the current review.
Recent advances in geographic information systems 
(GIS) and analytical approaches were utilised in the stud-
ies reporting geographic variation in CMRFs. These stud-
ies have demonstrated advances in various analytical 
tools and the potential for plotting area level risk parame-
ters. Geocoding and mapping of existing large population 
based datasets has become feasible with newer compu-
tational tools through linking location data; such as map 
co-ordinates, addresses or postcodes [42]. These tools 
have the capacity to visually display area based factors, 
in contrast with traditional table and graph methods, and 
this has the potential to enhance impact on subsequent 
area level health care policy development and resource 
allocation [43–45]. In addition, systematic quantitative 
analyses are possible with these spatial tools which cre-
ate opportunities to investigate the role of environmental 
factors in explaining any geographic aggregations beyond 
random effects [46].
National estimates of CVD have limited utility in 
informing prevention and management of CVD within 
discrete communities. The disease patterns at smaller 
areas may significantly differ from national and regional 
prevalence reports, thus small area analysis is important 
in order to understand local patterns and requirements 
[47]. Small-area level analyses also have the potential to 
reveal area level contexts and dependencies of CMRFs 
and such analyses can highlight areas for targeted pre-
ventive interventions.
CVD and its associated CMRFs continue to evolve as a 
major global health threat. It is the highest cause of mor-
tality and the highest absorber of health care expenditure 
in many developed nations [6, 48, 49]. Once diagnosed, 
the ongoing costs of care and productivity loss due to 
consequent disability and premature death creates a large 
economic burden not only to the individual and family, 
but to the nation—especially when half the people dying 
are found to be in their prime productive years [50]. Thus, 
CVD and its associated metabolic risk factors emerge as 
a threat not only to human health and life, but to the sus-
tainable development and economies of nations. Hence, 
improving public health program effectiveness in reduc-
ing CVD must be a research priority.
Limitations
Firstly, the cross sectional nature of the reviewed studies 
precluded causative interpretations. Second, the global 
representativeness of the review is limited mainly due to 
publication gaps from Asia–pacific and African regions 
of the World. Third, the scope of our review excluded 
examination of behavioural, dietary and activity related 
risk factors and also other area level characteristics to 
focus only on the biological proxies of CMRFs. Fourth, 
methodological heterogeneity within the retrieved stud-
ies prohibited a meta-analytical synthesis of the findings. 
The sample characteristics, geographical scales and the 
CMRFs’ risk profiles varied substantially across the stud-
ies impeding any further quantitative synthesis.
Recommendations and future directions
Finding geographic variation in CMRFs (if any) and its 
association with ASED may assist in understanding the 
contexts of risk. Such studies have the potential to inform 
contextual planning of interventions for prevention and 
management of cardiometabolic risk. However, most of 
the studies in this review do not report the spatial extents 
of their units of analysis. This is important as associa-
tions are likely to be different at different levels of aggre-
gation, and limits the ability to assess the likelihood of 
spatial scale effects in these studies [22, 23] known as the 
Modifiable Areal Unit Problem [51, 52]. When data are 
aggregated to larger geographic units, small-area anoma-
lies may be diluted or smoothed over [22]. Using smaller 
rather than larger area scales can help to reduce the like-
lihood of missing important small area anomalies [53]. 
Similarly, supplementing individual level data along with 
area level data could minimise group effects due to area 
level aggregation of data [53]. Leveraging both individ-
ual- and area-level data provides a more complete picture 
to inform planning, policy and practice [46, 53]. Future 
research directions should include hierarchical multilevel 
analyses to yield comprehensive picture of the contextual 
aspects of risk factors, to help aid both individual and 
area-level better preventive initiatives.
Conclusion
Cardiometabolic risk distribution varied significantly 
across different geographic scales reported in multi-
ple studies. In addition, there is strong evidence that 
area-level disadvantage is significantly associated with 
CMRFs, irrespective of individual-level characteristics. 
This review highlights the need for area-based preventive 
approaches in addition to individual-level approaches to 
prevent and control CMRFs and their consequent CVD 
outcomes.
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